Skip to main content
Monthly Archives

September 2022

Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins

Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins

By Scientific publications
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins

We have developed a statistical mechanics algorithm, TANGO, to predict protein aggregation. TANGO is based on the physico-chemical principles of b-sheet formation, extended by the assumption that the core regions of an aggregate are fully buried.

Our algorithm accurately predicts the aggregation of a data set of 179 peptides compiled from the literature as well as of a new set of 71 peptides derived from human diseaserelated proteins, including prion protein, lysozyme and b2-microglobulin. TANGO also correctly predicts pathogenic as well as protective mutations of the Alzheimer b-peptide, human lysozyme and transthyretin, and discriminates between b-sheet propensity and aggregation. Our results confirm the model of intermolecular b-sheet formation as a widespread underlying mechanism of protein aggregation. Furthermore, the algorithm opens the door to a fully automated, sequence-based design strategy to improve the aggregation properties of proteins of scientific or industrial interest.

Download publication
Nature Communications 2020 Michiels

Reverse engineering synthetic antiviral amyloids

By Scientific publications
Nature Communications 2020 Michiels

Human amyloids have been shown to interact with viruses and interfere with viral replication. Based on this observation, we employed a synthetic biology approach in which we engineered virus-specific amyloids against influenza A and Zika proteins.

Each amyloid shares a homologous aggregation-prone fragment with a specific viral target protein. For influenza we demonstrate that a designer amyloid against PB2 accumulates in influenza A-infected tissue in vivo. Moreover, this amyloid acts specifically against influenza A and its common PB2 polymorphisms, but not influenza B, which lacks the homologous fragment. Our model amyloid demonstrates that the sequence specificity of amyloid interactions has the capacity to tune amyloid-virus interactions while allowing for the flexibility to maintain activity on evolutionary diverging variants.

Download publication